Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2025-12-24 @ 6:40 PM
NCT ID:
NCT05953857
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of Kosaki or Penttinen syndrome
* Molecular diagnosis of an activating variant in PDGFRB gene
* Patient who has been informed and provide a written informed consent
Exclusion Criteria:
* Absence of clinical diagnosis of Kosaki or Penttinen syndrome
* Absence of molecular diagnosis of an activating variant in the PDGFRB gene.
* Patient who has not been informed and/or did not provide a written informed consent.
Sex:
ALL
Minimum Age:
0 Years
Maximum Age:
100 Years
Study:
NCT05953857
Study Brief:
Protocol Section:
NCT05953857